studies on glp 1 The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action Real-world studies of GLP-1 discontinuation

Clinical Update 3/27/2025 Semaglutide & Iron Absorption The GLP-1 agonist semaglutide (Ozempic, Wegovy) may reduce iron absorption from supplements, according to a recent study

In a phase 2 trial, cagrilintide at a dose of 2.4 mg led to a 9.7% weight reduction by week 26

Abstract This novel method enables specific measurement of the activation of hybrid receptors formed between the Insulin Receptor (IR) and the Insulin-like Growth Factor 1 Receptor (IGF1R)

plasma and buffy coats were separated, and the sedimented erythrocytes (1 mL) were collected in Eppendorf tubes and stored at 80 C for the redox status analysis

L-carnitine and weight loss: what does science say